The prescription savings platform GoodRx launched its new e-commerce solution on Thursday with over-the-counter birth control pill Opill as its launch partner. It follows another announcement the company made in the women’s health space last week: new affordability programs for menopause hormone therapies from Pfizer..

处方储蓄平台GoodRx于周四推出了新的电子商务解决方案，非处方避孕药Opill是其推出合作伙伴。此前，该公司上周在女性健康领域发布了另一项公告：辉瑞公司针对更年期激素疗法的新可负担性计划。。

Santa Monica, California-based GoodRx helps consumers compare prescription drug prices and get coupons. Through the new e-commerce solution, consumers can order health products and medications (such as Opill) on the GoodRx website and have them delivered to their homes. The company’s partnership with Perrigo, the maker of Opill, is GoodRx’s first collaboration in the over-the-counter space..

总部位于加利福尼亚州圣莫尼卡的GoodRx帮助消费者比较处方药价格并获得优惠券。通过新的电子商务解决方案，消费者可以在GoodRx网站上订购健康产品和药物（如Opill），并将其送到家中。该公司与Opill制造商Perrigo的合作是GoodRx在非处方药领域的首次合作。。

The e-commerce solution offers “that full seamless flow of someone being able to buy [Opill] and have it delivered to them, which makes total sense in birth control for privacy,” said Dorothy Gemmell, chief commercial officer at GoodRx, in an interview at the recent HLTH conference. “Also the generation taking birth control, they get everything else delivered.

GoodRx首席商务官多萝西·杰梅尔（DorothyGemmell）在最近的HLTH会议上接受采访时表示，电子商务解决方案提供了“能够购买（Opill）并将其交付给他们的完整无缝流程，这在隐私节育方面完全有意义”。“同样是采取节育措施的那一代人，他们得到了其他一切。

Why walk into a pharmacy?”.

为什么要走进药房？”。

presented by

提交人

Sponsored Post

赞助帖子

The Promise of Value-Based Care and MedTech Innovation

基于价值的护理和医疗技术创新的承诺

Monica Vajani, Executive Director for mHUB’s MedTech Accelerator, discusses how mHUB is helping innovators transition healthcare towards value-based care.

mHUB MedTech加速器的执行董事莫妮卡·瓦贾尼（MonicaVajani）讨论了mHUB如何帮助创新者将医疗保健转变为基于价值的护理。

By Monica Vajani - mHUB

作者：莫妮卡·瓦贾尼-mHUB

In July 2023, Opill was approved by the Food and Drug Administration as the first birth control pill available over the counter in the U.S. It is a progestin-only daily oral contraceptive and does not require a prescription. The approval of the pill was significant for its potential to greatly expand access to contraception, particularly for those who are uninsured or don’t have a regular physician (though some insurance plans are also covering Opill, according to its website).

2023年7月，Opill被美国食品和药物管理局批准为美国第一种非处方避孕药。它是一种仅含孕激素的每日口服避孕药，不需要处方。该药丸的批准对于极大地扩大避孕的可能性具有重要意义，特别是对于那些没有保险或没有正规医生的人（尽管根据其网站，一些保险计划也涵盖了Opill）。

On GoodRx’s platform, Opill costs $49.99 for a three-month pack..

在GoodRx的平台上，Opill的三个月套餐价格为49.99美元。。

Last week, GoodRx also announced new affordability programs for menopause hormone therapies with Pfizer. Eligible patients with a prescription can find exclusive cash prices for Pfizer’s menopause hormone therapies at over 70,000 pharmacies across the country through GoodRx. For example, consumers can purchase Prempro for about $98.84 on GoodRx, compared to the retail price of $372.99.

上周，GoodRx还宣布了与辉瑞公司合作的更年期激素治疗新的可负担性计划。符合条件的处方患者可以通过GoodRx在全国70000多家药店找到辉瑞更年期激素疗法的独家现金价格。例如，消费者可以在GoodRx上以约98.84美元的价格购买Prempro，而零售价为372.99美元。

It treats hot flashes and prevents osteoporosis. They can also get Estring (which treats vaginal irritation and dryness) at $249, versus the retail price of $655.89. They can get these drugs at a variety of pharmacy chains, including CVS, Walgreens, Walmart and Costco..

它治疗潮热并预防骨质疏松症。他们还可以获得249美元的限制（治疗阴道刺激和干燥），而零售价为655.89美元。他们可以在各种连锁药店买到这些药物，包括CVS、沃尔玛、沃尔玛和好市多。。

Research from GoodRx shows that list prices for menopause medications have risen by 58% since 2014. There is also uneven insurance coverage for menopause drugs, with some drugs having better coverage than others. In addition, those with menopause pay 45% more on healthcare costs than those who aren’t experiencing menopause, according to another study. .

GoodRx的研究表明，绝经药物的标价自2014年以来上涨了58%。更年期药物的保险范围也不均衡，一些药物的保险范围比其他药物更好。另外，根据另一项研究，更年期患者比未经历更年期的患者支付的医疗保健费用高45%。。

“Women in general, in healthcare, have been subject to what we call the ‘Pink Tax,’” Gemmell said. “Women pay more for healthcare overall, even if you take maternity out of it.”

杰梅尔说：“一般来说，在医疗保健领域，女性都要缴纳我们所谓的‘粉红税’。”。“总体而言，女性为医疗保健支付的费用更高，即使你不考虑生育。”

Sponsored Post

赞助帖子

The Future of Hospitals and Pharma Companies Will Depend on Strength of Healthcare Analytics Insights

PurpleLab® stands out from others in this sector by providing its data analytics services to several different groups of users across healthcare and pharma companies.

。

By Stephanie Baum

作者：StephanieBaum

In total, GoodRx works with over 150 brands, including pharmaceutical manufacturers and medical device companies, and more than 50 pharmaceutical brands are providing cash price options on the GoodRx platform. The company announced on Tuesday that the weight management solution QSYMIA is available for an exclusive cash price of $149 for a 30-day supply.

GoodRx总共与150多个品牌合作，包括制药制造商和医疗器械公司，50多个制药品牌正在GoodRx平台上提供现金价格选择。该公司周二宣布，QSYMIA体重管理解决方案30天的独家现金价格为149美元。

In July, it began offering Boehringer Ingelheim’s Humira biosimilar for $550 per two-pack..

7月，它开始提供勃林格殷格翰的Humira生物仿制药，每两包550美元。。

Photo: FotografiaBasica, Getty Images

照片：FotografiaBasica，Getty Images

Topics

主题

birth control

节育

GoodRx

古德克斯

menopause

更年期

Opill

Opil

Pfizer

辉瑞公司

MedCity News Daily Newsletter

MedCity新闻每日通讯

Sign up and get the latest news in your inbox.

注册并在收件箱中获取最新消息。

Enter your email address

输入您的电子邮件地址

Subscribe Now

立即订阅

We will never sell or share your information without your consent. See our privacy policy.

未经您同意，我们绝不出售或共享您的信息。请参阅我们的隐私政策。

More From MedCity News

更多来自MedCity新闻

BioPharma,

生物制药，

Pharma

制药

Novo Nordisk GLP-1 Drug Meets Goals of MASH Trial, Setting Stage for FDA & EMA Filings

诺和诺德GLP-1药物符合MASH试验的目标，为FDA和EMA备案奠定了基础

By Frank Vinluan

作者：Frank Vinluan

MedCity Influencers

MedCity影响者

Create a Winning Playbook for Employee Caregivers

By Qiana Martin

作者：Qiana Martin

MedCity Influencers

MedCity影响者

Innovations Shaping the Future of Kidney Care

创新塑造肾脏护理的未来

By John Erbey

作者：John Erbey

Sponsored Post

赞助帖子

Heard at HLTH 2024: Insights from Innovative Healthcare Executives

在HLTH 2024上听到：来自创新医疗保健高管的见解

By Stephanie Baum

作者：StephanieBaum